Central Strategic Intelligence for Biotech & Pharma.

ClarezAI is your strategic intelligence partner — integrating Medical Affairs expertise, AI-powered analytics, clinical innovation, and translational science to transform complex data into actionable insights that drive evidence-based decisions.

Retina AI Strategic Insight

The Hidden Friction

Obstacles between great science and decisive action.

Patterns that quietly stall biotech and pharma programs — and obscure the path from insight to execution.

Outdated Insights

Stale evidence limits planning confidence.

Fragmented Strategic Intelligence

Signals are scattered across teams.

Internal Thinking Reliance

Decisions over-index on internal assumptions.

Intuition-based Decisions

Judgment substitutes for objective evidence.

Internal Misalignment

Functions move without one shared direction.

Underpowered Execution

Strategy lacks resource-ready implementation.

Landscape Complexity

Markets, competitors, and evidence evolve fast.

Evolving Therapy Landscape

Innovation shifts the roadmap.

About ClarezAI

One integrated platform — multiple execution engines.

ClarezAI empowers biotech and pharmaceutical organizations with integrated strategic intelligence solutions that connect science, clinical development, and Medical Affairs through execution. Combining deep therapeutic expertise with AI-driven innovation, we deliver actionable insights that accelerate development, strengthen evidence generation, and maximize real-world impact.

Explore our products →

Our Products

Four products. One Strategic Intelligence Engine.

Each product is best-in-class on its own — and dramatically more powerful when combined as a vertically integrated stack across the product lifecycle.

ClarezAI MA — Medical Affairs Excellence

ClarezAI MA

Medical Affairs Excellence

Full-suite Medical Affairs function and support — strategy, medical communications, publications, congress, advisory boards, and KOL engagement — delivered cost-efficiently without building an entire internal team.

Learn more →
CASExAI — Clinical Trial Efficiency & Performance

CASExAI

Clinical Trial Efficiency & Performance

An AI-driven clinical platform — CTMS, SKYE (AI study-coordinator assistant), SARA (ePROs mobile app), Mobile Retina Clinic, and site engagement tools that accelerate enrollment and retention.

Learn more →
NRSS — Near-Real Surgical Systems

NRSS

Near-Real Surgical Systems

An AI-powered Near-Real Human Eye Model — concept-to-validation testing, PK/PD modeling, drug distribution, dose optimization, and surgical training and assessment.

Learn more →
ClinomicsAI — Deep Proteomic Analysis

ClinomicsAI

Deep Proteomic Analysis & Bioinformatics

Minimally invasive liquid biopsy proteomics built on Stanford-licensed IP — real-time molecular insights, drug-sensitive pathway discovery, safety pathway identification, and patient stratification.

Learn more →

The ClarezAI Advantage

From traditional approaches to transformative impact.

A unified strategic intelligence ecosystem replaces fragmented vendors, siloed data, and reactive decision-making.

Traditional Approach ClarezAI Approach
  • Fragmented vendors and disconnected systems Unified intelligence ecosystem
  • Siloed data and limited visibility Integrated, data-driven insights
  • Reactive decision-making Proactive strategic guidance
  • High operational overhead Scalable, cost-efficient expertise
  • Limited cross-functional coordination End-to-end lifecycle support

Delivering Measurable Impact

Strategic intelligence — translated into measurable outcomes.

Six measurable ways ClarezAI drives operational, clinical, and commercial impact across the product lifecycle.

Accelerate Drug Development

Compress development timelines through coordinated strategic intelligence and integrated execution support.

Reduce Operational Costs

Scale specialized expertise without scaling overhead — a more efficient operating model that maintains depth.

Improve Trial Success

AI-enabled identification, enrollment, engagement, and retention raise the probability of clean clinical outcomes.

Actionable Scientific Insights

Generate molecular, mechanistic, and translational insights that inform decisive development decisions.

Precise Patient Selection

Stratification and biomarker-guided selection enhance treatment response and precision-medicine outcomes.

Scale Medical Affairs

Expand credible MA capabilities efficiently across emerging and established biotech organizations.

Why Choose ClarezAI

Transforming Science into Therapeutic Impact.

ClarezAI unifies artificial intelligence, translational science, clinical development, and medical affairs into a single intelligence ecosystem. By connecting insights across the entire product lifecycle, we help biotechnology and pharmaceutical organizations accelerate development, reduce costs, and improve patient outcomes.

Four Reasons Organizations Choose ClarezAI

End-to-End Healthcare Intelligence

Unlike point solutions that address only one stage of development, ClarezAI integrates scientific discovery, clinical development, medical affairs, and real-world implementation into one connected platform.

Benefit: Better decisions through continuous intelligence across the entire product lifecycle.

Accelerate Development with AI-Driven Insights

Our Strategic Intelligence Engine combines AI, advanced analytics, and domain expertise to identify opportunities, optimize workflows, and support faster decision-making.

Benefit: Shorter development timelines and improved operational efficiency.

Improve Clinical and Commercial Success

From patient stratification and clinical trial optimization to KOL engagement and evidence generation, ClarezAI helps organizations increase the likelihood of successful therapeutic adoption.

Benefit: Improved trial outcomes, stronger evidence strategies, and enhanced market readiness.

Scale Expertise Without Scaling Costs

Access specialized expertise in Medical Affairs, Clinical Development, Translational Science, and Proteomics without building large internal teams.

Benefit: Enterprise-level capabilities with a more efficient and cost-effective operating model.

One Platform. Four Specialized Solutions. Unlimited Potential.

ClarezAI is the intelligence layer connecting science, clinical development, medical affairs, and patient care — creating a more efficient pathway from discovery to therapeutic impact.

Start a Conversation

Real Expertise

Seasoned biotech/pharma leadership with retina-specialized execution.

A true expertise team and network designed to convert deep ophthalmology experience into focused strategic advantage.

01

Executive Veterans

Biotech and pharma executive and leadership veterans across the development spectrum.

02

KOL Networks

Built-in key opinion leader networks to accelerate access and insight from day one.

03

Retina-Focused

Retina-specialized experts including MDs, PharmDs, and PhDs with deep ophthalmology command.

04

Proven MA Strategy

Medical Affairs strategy proven across multiple biotech and pharma launches.

05

100+ Publications

Publication development experience with 100+ presentations and manuscripts delivered.

Let's Work Together

Ready to unlock the full strategic value of your science?

Tell us where you are in development and what you're trying to achieve. We'll follow up to explore how ClarezAI can help.

Trusted by biotech and pharma teams who lead with science.

100+

Clinical trials (PI)

100%

FDA audit success

200+

Publications

2026

Ophthalmologist Power List